Since activated AKT induces protein synthesis via mTOR and downstream elements, the down regulation of NlAKTIP or inactivation of AKT should be able to inhibit various processes and delay the development of BPH. The gene discussed is AKT1; the disease is benign prostatic hyperplasia.